Production (Stage)
BioSyent Inc.
BIOYF
$8.59
-$0.0525-0.61%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 21.73% | -10.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.73% | -10.31% | |||
| Cost of Revenue | 56.95% | -22.71% | |||
| Gross Profit | 13.65% | -6.88% | |||
| SG&A Expenses | -47.16% | 102.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -40.76% | 87.83% | |||
| Operating Income | -34.30% | 58.29% | |||
| Income Before Tax | 36.77% | -26.28% | |||
| Income Tax Expenses | 27.92% | -6.87% | |||
| Earnings from Continuing Operations | 40.27% | -31.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.27% | -31.90% | |||
| EBIT | -34.30% | 58.29% | |||
| EBITDA | -38.01% | 72.62% | |||
| EPS Basic | 43.11% | -31.37% | |||
| Normalized Basic EPS | -36.29% | 62.70% | |||
| EPS Diluted | 42.23% | -31.12% | |||
| Normalized Diluted EPS | -36.49% | 63.05% | |||
| Average Basic Shares Outstanding | -1.98% | -0.79% | |||
| Average Diluted Shares Outstanding | -1.69% | -0.90% | |||
| Dividend Per Share | 8.41% | -2.73% | |||
| Payout Ratio | -0.24% | 0.41% | |||